Characteristics | Median (IQR) or (%) | |
---|---|---|
 | 18F | 68Ga |
Age (years) | 71(67–75) | 72(68–80) |
PSA (ng/ml) | 15.00(7.30–30.58) | 17.05(12.47–22.65) |
Gleason score | ||
 6 | 11(19.2) | 2(16.6) |
 7 | 20(35.0) | 6(50.0) |
 8 | 18(31.5) | 4(33.3) |
 9 | 5(8.7) |  |
 10 | 3(5.2) |  |
Risk classification | ||
 Low | 9(15.7) | 2(16.6) |
 Intermediate | 21(36.8) | 6(50.0) |
 High | 27(47.3) | 4(33.3) |
SUVmax | 11.53(4.95–21.50) | 10.32(5.67–18.10) |
GTV-MRI, cm3 | 2.80(1.50–7.20) | 2.60(1.23–4.43) |
GTV-PETVIS, cm3 | 3.30(1.50–9.20) | 1.80(0.58–2.60) |
GTV-PET/MRI, cm3 | 4.80(2.12–11.55) | 2.45(1.83–4.60) |
GTV-PET30%, cm3 | 21.70(6.80–37.10) | 4.10(2.23–27.85) |
GTV-PET40%, cm3 | 10.60(3.60–19.65) | 2.30(1.13–21.30) |
GTV-PET50%, cm3 | 5.30(1.80–10.95) | 2.85(0.68–14.45) |
GTV-PET60%, cm3 | 2.40(0.70–6.25) | 0.80(0.33–6.18) |